The impact of semaglutide on liver fat assessed by serial cardiac CT scans in patients with type 2 diabetes: Results from STOP trial.
Golub IS, Manubolu VS, Aldana-Bitar J, Dahal S, Verghese D, Alalawi L, Krishnan S, Kianoush S, Benzing T, Ichikawa K, Kinninger A, Fazlalizadeh H, Pourafkari L, Ahmad K, Susarla S, Mangaoang C, Ghanem AK, Javier DA, Hamal S, Roy SK, Budoff MJ.
Golub IS, et al. Among authors: javier da.
Nutr Metab Cardiovasc Dis. 2025 Sep;35(9):104036. doi: 10.1016/j.numecd.2025.104036. Epub 2025 Apr 5.
Nutr Metab Cardiovasc Dis. 2025.
PMID: 40287313
Clinical Trial.